Status:
COMPLETED
Corticosteroid Therapy on Glucose Control in Pregnant Women With Diabetes
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Pregnant Women
Eligibility:
FEMALE
18-52 years
Brief Summary
Preterm birth occurs in 25% of women with insulin requiring diabetes in pregnancy. The administration of corticosteroid therapy to accelerate fetal lung maturation is indicated in women at risk for pr...
Detailed Description
Preterm birth occurs in 25% of women with insulin requiring diabetes in pregnancy. The administration of corticosteroid therapy to accelerate fetal lung maturation is indicated in women at risk for pr...
Eligibility Criteria
Inclusion
- The study group will include pregnant women \> 18 years of age with insulin-requiring diabetes who will receive corticosteroid therapy to accelerate fetal lung maturation between 24 and 34 weeks of pregnancy. Only those women not in active labor and with singleton gestations will be included. A control group will be comprised of pregnant women with singleton gestations without insulin-requiring diabetes who will receive corticosteroid therapy also to accelerate fetal lung maturation.
Exclusion
- Women will be excluded if they have diet controlled diabetes, twins or higher gestation, are in active labor and anticipate imminent delivery, were previously on any form of steroid therapy, or who have or will be receiving beta-adrenergic medications.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00673543
Start Date
May 1 2008
End Date
September 1 2010
Last Update
May 11 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lyndon B. Johnson Hospital
Houston, Texas, United States, 77026
2
Memorial Hermann Hospital Texas Medical Center
Houston, Texas, United States, 77030